Finnish Neurotech Company Secures $1.9 Million Funding to Accelerate Commercialization of Real-Time Neuromodulation Technology
2026-04-02 15:49
Favorite

en.Wedoany.com Reported - Finnish neurotechnology company Audicin recently completed a $1.9 million funding round. This round includes private investment, follow-on support from Petteri Lahtela and Virpi Tuomivaara, as well as funding from Business Finland through its deep tech accelerator program. This funding brings the company's total raised capital to approximately $3 million and will be used to expand its real-time neuromodulation technology.

Audicin focuses on developing solutions based on brainwave entrainment, auditory engineering, and music neuroscience, aiming to enhance focus, promote stress recovery, boost productivity, and improve sleep. Its technology provides real-time background listening sessions that can adapt to physiological signals, enabling continuous, all-day neuromodulation.

The company's core product, Audicin for Apps, is an SDK that integrates real-time modulation protocols into digital health, performance, and consumer platforms. The SDK operates passively, triggered by biometric data, time, or in-app events, and is compatible with wearables like Oura, Apple Watch, Garmin, and Whoop, requiring no additional hardware.

Furthermore, Audicin is developing a standalone offline sleep headband designed for environments with limited mobile device access, suitable for sectors such as healthcare and defense. This device, based on low-frequency brainwave protocols, offers pre-configured recovery programs to support deep sleep.

Co-founder and CEO Laura Avonius stated: "We are committed to embedding neurological support into everyday environments, achieving real-time modulation without requiring dedicated user attention, and expanding into scenarios where recovery and performance are more challenging." The company has already seen early commercial interest in defense, performance, and health sectors, with a growing pipeline of enterprise opportunities and increased user engagement following product updates.

This funding will support the commercialization of Audicin's core products, including mobile apps, the sleep headband, and Audicin for Apps, as well as further product development and market expansion. Real-time neuromodulation technology is poised to play a greater role across multiple application scenarios, driving innovation in the neurotechnology field.

This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com